Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy

BACKGROUND: Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors to develop in the digestive tract. These tumors are highly resistant to conventional chemotherapy and only the introduction of imatinib mesylate has improved the prognosis of patients. However, Response Eval...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Da Riva, Luca, Bozzi, Fabio, Mondellini, Piera, Miccichè, Francesca, Fumagalli, Elena, Vaghi, Elena, Tarantino, Eva, Huber, Veronica, Gronchi, Alessandro, Tamborini, Elena, Pierotti, Marco A, Pilotti, Silvana, Bongarzone, Italia
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2011
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3192683/
https://ncbi.nlm.nih.gov/pubmed/21943129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-158
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים